Hearing: Making Health Care More Affordable: Lowering Drug Prices and Increasing Transparency

Subcommittee on Health, Employment, Labor, and Pensions (Committee on Education and Labor)

Mr. Frederick Isasi, J.D.
Executive Director, Families USA, Washington, D.C.

• Witness Statement [PDF] Added 09/26/2019 at 03:17 PM
• Witness Truth in Testimony [PDF] Added 09/26/2019 at 03:34 PM

Ms. Bari Talente, J.D.
Executive Vice President, Advocacy, National Multiple Sclerosis Society, Washington, D.C.

• Witness Statement [PDF] Added 09/26/2019 at 03:17 PM
• Witness Truth in Testimony [PDF] Added 09/26/2019 at 03:34 PM

Dr. Mariana P. Socal, MD, MS, MPP, Ph.D.
Assistant Scientist, Johns Hopkins Bloomberg School of Public Health, Department of Health Policy and Management, Baltimore, MD

• Witness Statement [PDF] Added 09/26/2019 at 03:17 PM
• Witness Truth in Testimony [PDF] Added 09/26/2019 at 03:34 PM

Mr. Christopher Holt
Director of Health Care Policy, American Action Forum, Washington, D.C.

• Witness Statement [PDF] Added 09/26/2019 at 03:17 PM
• Witness Truth in Testimony [PDF] Added 09/26/2019 at 03:34 PM

Mr. Craig Garthwaite
Associate Professor of Strategy, Northwestern University Kellogg School of Management, Evanston, IL

• Witness Statement [PDF] Added 09/26/2019 at 03:17 PM
• Witness Truth in Testimony [PDF] Added 09/26/2019 at 03:34 PM

Mr. David Mitchell
Founder, Patients For Affordable Drugs Now, Bethesda, Maryland

• Witness Statement [PDF] Added 09/26/2019 at 03:17 PM
• Witness Truth in Testimony [PDF] Added 09/26/2019 at 03:34 PM